Surgical Care Sciences, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu, Oulu University Hospital, Oulu, Finland.
Ann Surg. 2020 Feb;271(2):311-316. doi: 10.1097/SLA.0000000000002972.
To evaluate the impact of postoperative complications on health-related quality of life (HRQOL) up to 10 years after surgery for esophageal cancer.
The impact of postoperative complications on HRQOL past 5 years is unknown.
Some 616 patients undergoing open esophageal cancer surgery between April 2, 2001 and December 31, 2005 in Sweden were enrolled in this population-based, nationwide, and prospective cohort study. Exposure was the occurrence of predefined postoperative complications, and the outcome was HRQOL evaluated by validated European Organization for Research and Treatment of Cancer questionnaires at 6 months, 3, 5, and 10 years after surgery. Linear mixed models, adjusted for longitudinal HRQOL in the general population and confounders, provided mean score differences (MDs) with 95% confidence intervals (CIs) for each HRQOL item and scale in patients with or without postoperative complications.
At 10 years, 104 (17%) patients were alive and 92 (88%) answered the HRQOL questionnaires. Of these, 37 (40%) had at least 1 predefined postoperative complication. Twelve of the 25 scales and items were significantly worse in patients with postoperative complications 10 years after surgery, for example, physical function (MD -15, 95% CI -24 to -7), fatigue (MD 16, 95% CI 5-26), pain (MD 18, 95% CI 7-30), dyspnea (MD 15, 95% CI 2-27), insomnia (MD 20, 95% CI 8-32), and eating problems (MD 14, 95% CI 3-24) compared to patients without complications.
Postoperative complications are associated with considerably impaired HRQOL up to 10 years after esophageal cancer surgery.
评估食管癌手术后 10 年内术后并发症对健康相关生活质量(HRQOL)的影响。
术后并发症对 5 年以上 HRQOL 的影响尚不清楚。
在瑞典,2001 年 4 月 2 日至 2005 年 12 月 31 日期间,共有 616 名接受开放性食管癌手术的患者参与了这项基于人群、全国性、前瞻性队列研究。暴露因素是术后出现预定的并发症,结果是通过欧洲癌症研究与治疗组织的验证问卷在术后 6 个月、3 年、5 年和 10 年评估的 HRQOL。线性混合模型,调整了一般人群的纵向 HRQOL 和混杂因素,为有或没有术后并发症的患者提供了每个 HRQOL 项目和量表的平均得分差异(MD)及其 95%置信区间(CI)。
10 年后,104 名(17%)患者存活,92 名(88%)回答了 HRQOL 问卷。其中,37 名(40%)至少有 1 种预定的术后并发症。术后 10 年,有 25 个量表和项目中的 12 个在有术后并发症的患者中明显更差,例如身体功能(MD-15,95%CI-24 至-7)、疲劳(MD16,95%CI5-26)、疼痛(MD18,95%CI7-30)、呼吸困难(MD15,95%CI2-27)、失眠(MD20,95%CI8-32)和进食问题(MD14,95%CI3-24)。
食管癌手术后 10 年内,术后并发症与 HRQOL 明显受损相关。